Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Thyroid Nodule 1Prostatic Neoplasms 1Primary Peritoneal Neoplasm 1Ischemia 1Hemorrhage 1Cholecystolithiasis 1Blood Loss, Surgical 1

Interventions

Tranexamic Acid 13Sodium Chloride 4Misoprostol 4Saline Solution 3Enoxaparin 3carbetocin 2Tourniquets 2Ringer's Lactate 2Oxytocin 2Endoscopic Mucosal Resection 2Dalteparin 2Aspirin 2maleimide-polyethylene glycol-modified hemoglobin, MP4 1bemiparin 1Vitamin B 6 1Vasopressins 1Uterine Myomectomy 1Uterine Artery Embolization 1Ultrasonography 1Tinzaparin 1Thoracic Surgery, Video-Assisted 1Terlipressin 1Sutures 1Surveys and Questionnaires 1Surgicel 1Standard of Care 1Solutions 1Sensitivity Training Groups 1Rivaroxaban 1Ringer's Solution 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Hemorrhage × Ringer's Solution × Clear all
NCT00425334 2013-08-19

Safety Study of HemospanĀ® in Prostatectomy Patients

Sangart

Phase 2 Completed
20 enrolled
Genitourinary

Hemorrhage, Ischemia, Prostatic Neoplasms, Blood Loss, Surgical

Data powered by HemOnc (CC BY 4.0) Colophon ⚔